Banner

Grant will fund study of advanced imaging devices

Article

Cleveland-A $6 million federal grant will allow researchers at the Cleveland Clinic Cole Eye Institute to delve into the study of advanced imaging techniques used to diagnose and monitor glaucoma.

Related Videos
Related Content

Kriya announces exclusive license, collaboration, agreement with Everads to advance gene therapies for diseases in ophthalmology, Including GA

September 28th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

David Huang, MD, PhD, receives Lasker Award for transformative imaging technology

September 28th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

Thea Pharma rolls out latanoprost ophthalmic solution 0.005% in the US

September 27th 2023

Kriya announces exclusive license, collaboration, agreement with Everads to advance gene therapies for diseases in ophthalmology, Including GA

September 28th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

David Huang, MD, PhD, receives Lasker Award for transformative imaging technology

September 28th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

Thea Pharma rolls out latanoprost ophthalmic solution 0.005% in the US

September 27th 2023

Kriya announces exclusive license, collaboration, agreement with Everads to advance gene therapies for diseases in ophthalmology, Including GA

September 28th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

David Huang, MD, PhD, receives Lasker Award for transformative imaging technology

September 28th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

Thea Pharma rolls out latanoprost ophthalmic solution 0.005% in the US

September 27th 2023
© 2023 MJH Life Sciences

All rights reserved.